Skip to main content
Back To Top Top Back To Top
This website publishes administrative rules on their effective dates, as designated by the adopting state agencies, colleges, and universities.

Rule 4729:5-9-02.5 | Patient profiles.

 

All institutional pharmacies shall maintain a patient profile system which shall provide for immediate retrieval of information regarding those patients who have received medications from that pharmacy.

(A) All patient profile systems shall maintain, at a minimum, the following data:

(1) The patient's data record, which shall consist of, but is not limited to, the following information:

(a) Full name of the patient for whom the drug is intended.

(b) Patient's date of birth.

(c) Patient's gender, if provided.

(d) A list of current patient specific data consisting of at least the following, if made known to the pharmacist or agent of the pharmacist:

(i) Drug related allergies;

(ii) Previous drug reactions;

(iii) History of or active chronic conditions or disease states; and

(iv) Other drugs, including nonprescription drugs, devices and nutritional supplements used on a routine basis.

(e) The pharmacist's comments relevant to the individual patient's drug therapy, including any other necessary information unique to the specific patient or drug.

(2) The patient's drug therapy record, which shall contain the following information for all medications dispensed by the pharmacy within the last twelve months.

(a) The original medication order;

(b) Date and time of issuance of the medication order by the prescriber;

(c) Full name of the prescriber;

(d) The prescriber's credential (MD, NP, PA, etc.);

(e) Directions for use;

(f) The proprietary name, if any, or the generic name and the name of the distributor or national drug code of the drug or device dispensed; and

(g) The strength, dosage form, route of administration, and quantity of the drug or device dispensed.

(B) An institutional pharmacy shall make a reasonable effort to obtain a patient's medical history necessary to conduct a prospective drug utilization review.

(C) The patient profile shall be maintained for a period of not less than one year from the date of the last entry in the profile record. This record may be a hard copy or maintained as a part of computerized system.

Last updated February 1, 2022 at 9:22 AM

Supplemental Information

Authorized By: 4729.26, 3719.28
Amplifies: 4729.54
Five Year Review Date: 2/1/2027